Equity (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Schedule of warrants outstanding

	Shares of Common Stock Issuable from Warrants Outstanding as of				Weighted
	March 31,		December 31,		Average
Description	2022		2021		Exercise Price		Expiration
Series F		-		7,246	$	3.45	February 23, 2022 & March 9, 2022
Series G		460,250		460,250	$	2.68	July 21, 2022
Series H		910,000		910,000	$	2.75	October 16, 2022
Series I		10,335,000		10,335,000	$	2.00	November 26, 2025
Total		11,705,250		12,296,912

Schedule of stock option activity

	Number of Options			Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ($)
Outstanding at December 31, 2020		5,895,570			2.45
Granted		50,000			1.72
Forfeited		(2,805,571	)		2.74
Outstanding at September 30, 2021		3,139,999			2.17
Forfeited		(40,000	)		1.79
Outstanding at March 31, 2022		3,099,999			2.17		4.30		-
Vested and exercisable at March 31, 2022		2,699,999			2.02		4.30		-

Condensed Income Statement [Table Text Block]

	Three Months Ended March 31,
	2022		2021
Research and development	$	217,500	$	278,815
General and administrative		5,500		(1,153,575	)
Total	$	223,000	$	(874,760	)